The Supreme Court hears arguments Tuesday in a challenge that could limit access to a widely used drug for medication abortions, reshape health care policy and upend the Food and Drug Administration’s regulation process.
The justices will focus on a decision from the U.S. Court of Appeals for the 5th Circuit that found the FDA erred when it expanded how and when the abortion drug mifepristone can be dispensed.
The drug is used in more than half of U.S. abortions, and the decision would impact access to the drug nationwide, even in states that do not restrict abortion rights.
